Glenn Coleman
At a glance: Glenn Coleman is CFO at Charles River Laboratories (CRL). Their latest SEC Form 4, filed Oct 2, 2026, reported a purchase of $3K. On file: 1 purchase line ($3K) and 0 sale lines ($0).
Disclosed holdings: about $8.7M of CRL stock: 27,762 shares reported on their latest Form 4 (filed Oct 2, 2026), valued at the Nov 20, 2026 close of $314.32. This counts only CRL shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Glenn Coleman's InsiderPrint
2 trades from SEC Form 4 filings, 2023 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (2)
- Dent inward: a sale (0)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | CRLCharles River Laboratories International, Inc.First buy | Buy | 1027,762 held (+0%) | $297.43 | $3K | +5.7% |
- Buy
CFO Glenn Coleman bought $3K of CRL at $297.43 — first open-market purchase in our records.
Follow Glenn Coleman
Get one email when Glenn Coleman files a new purchase or sale. Free.
At most one email a day about Glenn Coleman, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.